Aimed Alliance’s Director of Medical Affairs, Dr. Shannon Ginnan, testified on an innovative buprenorphine subdermal implant under consideration for approval…
Aimed Alliance has signed on to the Coalition for Accessible Treatments’ letter commenting on the proposed rule, Notice of Benefit…
Aimed Alliance Report Reveals True Drivers of Health Care Costs in the United States America’s Misplaced Anger at Drug Makers:…
Administration Must Instead Focus on Exploitation and Profiteering by Insurers to Address Rising Health Care Costs November 5, 2015 – Washington,…
Aimed Alliance has signed on to the “I Am Essential” coalition’s letter, urging the United States Department of Health and…
FOR IMMEDIATE RELEASE September 18, 2015 CONTACT: Mike Rudin Shirley & Banister Public Affairs 703-739-5920/800-536-5920 [email protected] Health Insurance Watchdog Sets…
Earlier today, Aimed Alliance’s Director of Public Policy, Stacey L. Worthy, submitted a comment to the U.S. Food and Drug…
Today, Aimed Alliance presented testimony before a joint meeting of the U.S. Food and Drug Administration’s Anesthetic and Analgesic Drug…
Today, the National Health Council sent a letter signed by Aimed Alliance and 250 other organizations to the Chairman of…
